序号 |
标题 |
次数 |
作者 |
发布时间 |
88606 |
三氮唑卟啉配位聚合物的结构特点 |
305 |
wyh |
2024-11-19 |
88607 |
BSA-四(4-羟基苯基)卟啉锌配合物;BSA-ZnTpHPP |
113 |
h |
2024-11-19 |
88608 |
HPP-PGMA/SiO2;PGMA/SiO2固载金属卟啉 |
165 |
h |
2024-11-19 |
88609 |
卟啉基共轭有机聚合物的基本结构 |
163 |
wyh |
2024-11-19 |
88610 |
四苯基卟啉铜(CuTPP) |
101 |
h |
2024-11-19 |
88611 |
DSPE-PEG4-DBCO,CAS:2112738-14-2,磷脂-四聚乙二醇-二苯基环辛炔 |
116 |
zyl |
2024-11-19 |
88612 |
四(对-磺酸钠苯基)卟吩(Na4TSPP) |
126 |
h |
2024-11-19 |
88613 |
卟啉-脂质体靶向药物的作用机制 |
149 |
wyh |
2024-11-19 |
88614 |
MnTM4PyP/MT;meso-四(4-N-甲基吡啶基)锰卟啉/蒙脱土 |
136 |
h |
2024-11-19 |
88615 |
氨基-六聚乙二醇-羧酸,Dbco-Amine TFA,CAS号:2007915-94-6 |
112 |
zyl |
2024-11-19 |
88616 |
BSA-CoTPP;水溶性牛血清白蛋白-四苯基卟啉钴金属复合物 |
126 |
h |
2024-11-19 |
88617 |
卟啉AIE荧光分子复合材料 |
128 |
wyh |
2024-11-19 |
88618 |
NPP-GMA/MMA;对硝基苯基卟啉功能化聚合物微球GMA/MMA |
147 |
h |
2024-11-19 |
88619 |
ML(4R-p-TPP)-TiO2;卟啉光敏化半导体材料TiO2 |
186 |
h |
2024-11-19 |
88620 |
5-(4-硝基苯基)-10,15,20-苯基卟啉(TPP-N1) |
115 |
h |
2024-11-19 |
88621 |
离子型锰卟啉四-(1,3-二甲基-2-正丁基-4-氯咪唑基)锰卟啉六氟磷酸盐([MnTMBuMimP][PF6]5)(A2) |
139 |
h |
2024-11-19 |
88622 |
阳离子卟啉四-(4-三甲铵基苯基)卟啉(Pd-TAPP) |
210 |
h |
2024-11-19 |
88623 |
CY5.5标记左旋聚乳酸(CY5.5-Poly(L-lactic acid)) |
113 |
WYQ |
2024-11-19 |
88624 |
吲哚菁绿标记卡泊三醇(ICG-Calcipotriene) |
111 |
WYQ |
2024-11-19 |
88625 |
CY5.5标记卡泊三醇(CY5.5-Calcipotriene) |
121 |
WYQ |
2024-11-19 |
88626 |
CY2标记葡萄糖酸(CY2-Gluconic acid) |
89 |
WYQ |
2024-11-19 |
88627 |
含有二硫键的聚合物胶束 |
106 |
wyh |
2024-11-19 |
88628 |
锌卟啉功能单体5-(4-甲基丙烯酰氧苯基)-10,15,20-三苯基卟啉锌(ZnMOTPP) |
125 |
h |
2024-11-19 |
88629 |
CY2标记替加环素(CY2-Tigecycline) |
106 |
WYQ |
2024-11-19 |
88630 |
荧光素标记替加环素(FITC-Tigecycline) |
155 |
WYQ |
2024-11-19 |
88631 |
含吡啶二硫键的磁性纳米粒子 |
95 |
wyh |
2024-11-19 |
88632 |
邻氯四苯基卟啉锰(TClTPPMnCl) |
104 |
h |
2024-11-19 |
88633 |
CoTTP-TiO2;5,10,15,20-四(2-噻吩基)金属卟啉钴修饰TiO2光催化剂 |
219 |
h |
2024-11-19 |
88634 |
二硫键交联的鸟氨酸/半胱氨酸共聚物 |
113 |
wyh |
2024-11-19 |
88635 |
CY7.5标记白藜芦醇(CY7.5-Resveratrol) |
104 |
WYQ |
2024-11-19 |
88636 |
荧光素标记葡萄糖酸(FITC-Gluconic acid) |
183 |
WYQ |
2024-11-19 |
88637 |
水溶性的金属5,10,15,20-四-(4-对磺酸基苯基)-卟啉;Metallo-TPPS |
129 |
h |
2024-11-19 |
88638 |
含有二硫键的金属间卟啉衍生物 |
186 |
wyh |
2024-11-19 |
88639 |
CY7.5标记人纤维蛋白原(CY7.5-HUMAN FIBRINOGEN) |
139 |
WYQ |
2024-11-19 |
88640 |
ETIO型镍卟啉C35-(ETIO-Ni) |
93 |
h |
2024-11-19 |
88641 |
吲哚菁绿标记聚乳酸(ICG-Polylactic acid) |
102 |
WYQ |
2024-11-19 |
88642 |
DBCO-PEG1-acid,CAS号2228857-38-1 ,二苯并环辛炔-PEG1-羧酸 |
97 |
zyl |
2024-11-19 |
88643 |
多种GSH响应的含二硫键前药和药物输送体系 |
343 |
wyh |
2024-11-19 |
88644 |
四(间甲基苯基)卟啉(Tm-MPP) |
125 |
h |
2024-11-19 |
88645 |
水难溶性金属卟啉(MP) |
226 |
h |
2024-11-19 |
88646 |
四(4-羧基苯基)锰卟啉/硫化锌;Mn TCPP/ZnS |
166 |
h |
2024-11-19 |
88647 |
TCO-PEG4-DBCO,CAS号1801863-88-6,反式环辛烯-四聚乙二醇-二苯并环辛炔 |
133 |
zyl |
2024-11-19 |
88648 |
二硫键修饰的介孔二氧化硅微球 |
122 |
wyh |
2024-11-19 |
88649 |
BDP FL DBCO,CAS号2093197-94-3,氟化硼二吡咯-二苯并环辛炔 |
98 |
zyl |
2024-11-19 |
88650 |
疏水性化合物-二硫键共价连接疏水性化合物 |
245 |
wyh |
2024-11-19 |